Description: This report, part of the Society of Actuaries [SOA] ‘Experience Studies – Business Practice Surveys,’ presents the results of a survey conducted by the SOA Committee on Life Insurance Mortality and Underwriting Surveys – Regulation XXX Survey Subcommittee. The purpose of the survey was to explore the actions companies took on their term products in response to the introduction of the NAIC Valuation of Life Insurance Policies Model Regulation [Regulation XXX] and Actuarial Standard of Practice No. 40, including the development of companies' ‘X factors,’ the associated annual X factor certification process, and how Regulation XXX impacted the companies' level term pricing.

Description: Full version of Product Matters, January 2002, Issue No. 52.

Description: The New 2001 CSO: Implications for Universal Life Plans

Description: This report presents the results of a survey of the actions companies took on their term products in response to the introduction of the NAIC Valuation of Life Insurance Policies Model Regulation, ‘Regulation XXX,’ and Actuarial Standard of Practice No. 40. The survey also explores the development of companies' X factors, the associated annual X factor certification process and how Regulation XXX impacts the companies' level term pricing. The survey was conducted by the Regulation XXX Survey Subcommittee of the Society of Actuaries Life Insurance Mortality and Underwriting Survey Committee. Common survey responses to Regulation XXX included consideration of reinsurance, changes in product design, the most common changes reported being the length of the guarantee period and the level of the gross premiums, and changing rates on existing products.

Description: This report, part of the Society of Actuaries [SOA] ‘Experience Studies – Business Practice Surveys,’ presents the results of a survey conducted by the SOA Committee on Life Insurance Mortality and Underwriting Surveys - Mortality Improvement Survey Subcommittee. The purpose of the survey was to explore life insurance company practices regarding the use of a mortality improvement assumption in the pricing of life insurance products.